The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response
Oncotarget · 16.05.2024 · 15 (1) · 313-325
DOI: 10.18632/oncotarget.28585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, online erschienen am 16.05.2024. Verfasst von Lulzim Shkreta und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Protein-Tyrosine Kinases, Protein Kinase Inhibitors, Cell Proliferation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada.
- International Center for Infectiology Research (CIRI), INSERM U1111, CNRS UMR5308, Université de Lyon (UCBL1), Lyon, France.
- Institut de recherches cliniques de Montréal, Montréal, QC, Canada.
- Department of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke and Institut de Pharmacologie, Sherbrooke, QC, Canada.
- Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.
- Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Förderung
- NIH HHS
Zitieren
APA
Shkreta, L., Toutant, J., Delannoy, A., Durantel, D., Salvetti, A., Ehresmann, S., Sauvageau, M., Delbrouck, J. A., Gravel-Trudeau, A., Comeau, C., Huard, C., Coulombe-Huntington, J., Tyers, M., Grierson, D., Boudreault, P. L., & Chabot, B. (2024). The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response. Oncotarget, 15(1), 313-325. https://doi.org/10.18632/oncotarget.28585
Vancouver
Shkreta L, Toutant J, Delannoy A, Durantel D, Salvetti A, Ehresmann S, et al. The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response. Oncotarget. 2024;15(1):313-325. doi:10.18632/oncotarget.28585
BibTeX
@article{Shkreta2024,
author = {Shkreta, Lulzim and Toutant, Johanne and Delannoy, Aurélie and Durantel, David and Salvetti, Anna and Ehresmann, Sophie and Sauvageau, Martin and Delbrouck, Julien A and Gravel-Trudeau, Alice and Comeau, Christian and Huard, Caroline and Coulombe-Huntington, Jasmin and Tyers, Mike and Grierson, David and Boudreault, Pierre-Luc and Chabot, Benoit},
title = {The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response},
journal = {Oncotarget},
year = {2024},
volume = {15},
number = {1},
pages = {313--325},
doi = {10.18632/oncotarget.28585}
}
EUVIMED